Top compounds associated with response to CBL


Feature Type Standardized
Nominal ANOVA
mRNA AEW541 CCLE pan-cancer AAC -0.0047 0.9
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.0034 0.9
mRNA 5-FU CTRPv2 pan-cancer AAC -0.0033 0.9
mRNA BRD-K34099515 CTRPv2 pan-cancer AAC -0.0072 0.9
mRNA KIN001-102 GDSC1000 pan-cancer AAC -0.0028 0.9
mRNA CHM-1 CTRPv2 pan-cancer AAC -0.0028 0.9
mRNA Pazopanib GDSC1000 pan-cancer AAC -0.0031 0.9
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.0027 0.9
mRNA AT13387 CTRPv2 pan-cancer AAC -0.0036 0.9
mRNA KW-2449 CTRPv2 pan-cancer AAC -0.0024 0.9
Download CSV